Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Affymetrix, Inc.    AFFX

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/24/2016 03/28/2016 03/29/2016 03/30/2016 03/31/2016 Date
14.93(c) 14.1(c) 14.07(c) 13.99(c) 14.01(c) Last
4 331 106 9 212 070 12 386 729 4 975 092 5 030 402 Volume
-1.19% -5.56% -0.21% -0.57% +0.14% Change
More quotes
Company
Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis.It provides life science and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.The company was founded by Stephen P. A. Fodor in 1992 and... 
More about the company
Latest news on AFFYMETRIX, INC.
2016 AFFYMETRIX : Receives a Hold from Cantor Fitzgerald (Cantor Bryan Brokmeier Comm..
2016 AFFYMETRIX : Grant Supports Outcomes Research for Noninvasive Genomic Profiling
2016 AFFYMETRIX : Entry into a Material Definitive Agreement, Termination of a Materi..
2016 AFFYMETRIX : Determines Unsolicited Proposal from Origin Technologies Could Lead..
2016DJTHERMO FISHER SCIENTIFIC : Completes Acquisition of Affymetrix
2016DJTHERMO FISHER SCIENTIFIC : Completes Acquisition of Affymetrix
2016 AFFYMETRIX : Origin Significantly Enhances All-Cash Offer for Affymetrix
2016 AFFYMETRIX : Former Affymetrix Senior Executives Propose to Acquire Affymetrix f..
2016 AFFYMETRIX : Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit A..
2016 THERMO FISHER SCIENTIFIC : Affymetrix Reaffirms Support For Thermo Fisher Merger..
More news
Sector news : Bio Diagnostics & Testing
02/27DJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
More sector news : Bio Diagnostics & Testing
News from SeekingAlpha
2016 WEEK IN REVIEW : Deals Dominate China Biopharma News
2016 IBM Buys Salesforce.com Cloud Consultant
2016 30% Annual Return From This Stock
2016 *Except For Amazon
2016 WALL STREET BREAKFAST : Yellen Speech Takes Center Stage
Advertisement
Chart AFFYMETRIX, INC.
Duration : Period :
Affymetrix, Inc. Technical Analysis Chart | AFFX | US00826T1088 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Seth H. Hoogasian Chief Executive Officer & Secretary
Robert H. Trice Independent Director
Gary S. Guthart Director
David A. Weber Chief Commercial Officer
Kim Caple Senior Vice President & GM-Clinical Business
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AFFYMETRIX, INC.0.00%0
MIRACA HOLDINGS INC.-1.33%2 644
BEIJING STRONG BIOTECH..--.--%1 470
GENSCRIPT BIOTECH CORP10.00%889
SEEGENE INC--.--%800
INNATE PHARMA-29.84%586
More Results